• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Exclusives
    • Nutraceuticals
    • Markets
    • Health
    • Jobs
    • Events
    • Buyers' Guide
    • Showcases
    • More
  • Magazine
  • News
  • Exclusives
  • Nutraceuticals
  • Markets
  • Health
  • Jobs
  • Events
  • Buyers' Guide
  • Showcases
  • Current & Past Issues
    Features
    Columns
    Editorials
    Digital Edition
    Subscribe Now
    Advertise Now
    eNewsletter
    Editorial Guidelines
    Top Features
    Citrus Support for the Blood Glucose-Immune System Connection

    A Glance At The Eye Health Market

    The Value of Vitamin D Testing

    A Growing Need for Mineral Supplementation

    More Than Just A Trend: Supplements Embedded in Consumer Health Regimens
    Breaking News
    Certifications, Approvals and Patents
    Exclusives
    Industry & Market News
    People
    Products
    Regulatory
    Research
    Supplier News
    Supplier Insights
    Live From Shows
    Top News
    Martin Bauer Group Acquires Majority Stake in Beverage Company Power Brands

    Gencor Announces Positive Results in VeriSperse Bioavailability Study

    PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC

    Nutrition21 Launches Cosmeceutical Ingredient Lustriva

    Indena Becomes First Company in Italy Authorized to Produce CBD
    Exclusives
    Blogs & Guest Articles
    Health E-Insights
    Area Code 420
    eBook
    Antioxidants
    Dairy-Based Ingredients
    Enzymes
    Fatty Acids
    Fiber & Carbohydrates
    Green Foods
    Herbs & Botanicals
    Marine Nutraceuticals
    Minerals
    Omega 3s
    Probiotics & Prebiotics
    Proteins, Peptides, Amino Acids
    Sweeteners
    Vitamins

    Martin Bauer Group Acquires Majority Stake in Beverage Company Power Brands

    Gencor Announces Positive Results in VeriSperse Bioavailability Study

    PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC

    Nutrition21 Launches Cosmeceutical Ingredient Lustriva

    Indena Becomes First Company in Italy Authorized to Produce CBD
    Consumer Trends
    Contract Manufacturing
    Cosmeceuticals / Nutricosmetics
    Delivery & Dosage Technologies
    Dietary Supplements
    Flavors & Colors
    Functional Foods & Beverages
    Healthcare Trends
    Medical Nutrition
    Mergers & Acquisitions
    Natural/Organic
    Nutrition Bars
    Packaging
    Pet Nutraceuticals
    Quality & Safety
    Regulations
    Research
    Testing
    World Markets

    Martin Bauer Group Acquires Majority Stake in Beverage Company Power Brands

    Gencor Announces Positive Results in VeriSperse Bioavailability Study

    PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC

    Nutrition21 Launches Cosmeceutical Ingredient Lustriva

    Indena Becomes First Company in Italy Authorized to Produce CBD
    Bone & Joint Health
    Cancer Risk
    Cardiovascular Health
    Cognitive Function
    Diabetes & Blood Sugar Management
    Digestive Health
    Energy
    Eye Health
    Healthy Aging
    Immune Function
    Infant & Children's Health
    Inflammation
    Men's Health
    Mood Health & Sleep
    Oral Health
    Sexual & Reproductive Health
    Skin Health
    Sports Nutrition
    Weight Management/Weight Loss
    Women's Health

    Gencor Announces Positive Results in VeriSperse Bioavailability Study

    PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC

    Nutrition21 Launches Cosmeceutical Ingredient Lustriva

    Preliminary Study Links Markers of Impaired Bone Health to Vegan Diet

    Refined Grains Linked to Heart Attack Risk, Early Death
    Industry Events
    Live From Show Events
    Webinars
    All Companies
    Categories
    Trade Associations
    Company Capabilities
    International Buyers Guide Companies
    Gencor

    Aiya America (Matcha by Aiya)

    KLK OLEO - Davos Life Science

    Indena USA, Inc.

    Sabinsa Corporation
    Companies
    Product Releases
    News Releases
    Literature / Brochures
    White Papers
    Jobs
    VIdeos
    Services
    Add New Company
    International Buyers Guide Companies
    Gencor

    KLK OLEO - Davos Life Science

    AIDP

    Bioenergy Life Science, Inc. (BLS)

    Sabinsa Corporation
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Digital Edition
      • eNewsletter Archive
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
    • Breaking News
    • Buyers' Guide
      • All Companies
      • Categories
      • Trade Associations
      • Company Capabilities
    • Nutraceuticals
      • Antioxidants
      • Dairy-Based Ingredients
      • Enzymes
      • Fatty Acids
      • Fiber & Carbohydrates
      • Green Foods
      • Herbs & Botanicals
      • Marine Nutraceuticals
      • Minerals
      • Omega 3s
      • Probiotics & Prebiotics
      • Proteins, Peptides, Amino Acids
      • Sweeteners
      • Vitamins
    • Markets
      • Consumer Trends
      • Contract Manufacturing
      • Cosmeceuticals / Nutricosmetics
      • Delivery & Dosage Technologies
      • Dietary Supplements
      • Flavors & Colors
      • Functional Foods & Beverages
      • Healthcare Trends
      • Medical Nutrition
      • Mergers & Acquisitions
      • Natural/Organic
      • Nutrition Bars
      • Packaging
      • Pet Nutraceuticals
      • Quality & Safety
      • Regulations
      • Research
      • Testing
      • World Markets
    • Health
      • Bone & Joint Health
      • Cancer Risk
      • Cardiovascular Health
      • Cognitive Function
      • Diabetes & Blood Sugar Management
      • Digestive Health
      • Energy
      • Eye Health
      • Healthy Aging
      • Immune Function
      • Infant & Children's Health
      • Inflammation
      • Men's Health
      • Mood Health & Sleep
      • Oral Health
      • Sexual & Reproductive Health
      • Skin Health
      • Sports Nutrition
      • Weight Management/Weight Loss
      • Women's Health
    • Online Exclusives
    • Webinars
    • Slideshows
    • Blogs & Guest Articles
    • Health E-Insights
    • Videos
    • Podcasts
    • eBook
    • Infographics
    • Whitepapers
    • Research
      • TrendSense
      • Monograph Center
      • White Papers
      • Research News
    • Jobs
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Supplier Showcases
      • Companies
      • Product Releases
      • News Releases
      • Literature / Brochures
      • White Papers
      • Jobs
      • VIdeos
      • Services
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    Features

    Manufacturing Equipment Technology & Trends

    Potent drug products, delivery systems, continuous manufacturing, and digitization drive innovation.

    Manufacturing Equipment Technology & Trends
    Related CONTENT
    • Oral Solids Endure & Evolve
    • Bone & Joint Formulas Provide Foundations for Fitness
    • GOED Releases Updated Omega-3 Ingredient Market Report
    • FDA Plans to Modernize Dietary Supplement Regulations
    • Kerry Launches Non-GMO Yeast as Natural Solution for Acrylamide Reduction
    By Kristin Brooks, Managing Editor, Contract Pharma03.01.19
    Rapid advances in pharma and biopharma drug development are resulting in an increasing number of complex and niche therapies. This evolution is impacting manufacturing processes and equipment needs. Demand for flexibility continues to be the driving force behind the latest equipment. Small batches of specialized drug products, such as highly potent and cytotoxic drugs that require containment, various drug delivery systems, continuous manufacturing, and digitization are among the main factors impacting manufacturing and equipment. Contract Pharma spoke with leading manufacturing equipment suppliers and contract manufacturers about the latest pharma and biopharma trends, new capabilities, complexities, and customer needs.

    Evolving Pharma/Biopharma Trends
    The continued evolution from mainstream, mass produced pharmaceuticals to more specialized therapies, has required a complete concept change in manufacturing and processes for pharma companies. “Highly specialized products in small quantities and different drug delivery systems present a challenge for pharmaceutical companies,” said Jan Deininger, editor at Optima. “It makes a change in thinking necessary since niche products require a completely different production process than blockbuster pharmaceuticals. Pharmaceutical companies that produce small quantities need flexible machines that can process small batch sizes and different container types. At the same time, it is essential to maintain the high level requirements for product quality and patient safety,” Deininger noted.

    As a result, the demands on the flexibility of equipment systems are increasing. For example, she said smaller batch sizes have to be mastered and different containers such as syringes, vials and cartridges have to be filled on a single line.

    With more niche products coming to market, Tim Saarinen, chief operating officer for Maruho Hatsujyo Innovations (MHI), said, “The number of products and product packaging to achieve different presentations to the end user has been increasing. With fewer blockbuster products and more moderate scale products coming through the pharmaceutical pipeline, companies are more anxious to differentiate products based on customer experiences.”

    Meanwhile, eliminating the risks associated with exposure to highly potent or cytotoxic drugs requires high containment equipment solutions. Kat Jones, PCI’s director of marketing and commercial operations, said one of the largest trends in recent years has been unprecedented growth in the number of molecules being classified as “potent,” primarily driven by the oncology market, as well as therapy areas including pain and CNS disorders. She said, “Such molecules require special handling to protect both operators and the environment, and although historically as an industry we have relied on personal protective equipment (PPE), guidelines including those issued by the International Society for Pharmacoepidemiology (ISPE) indicate that preferred and best practice solutions should include contained engineering equipment whereby the molecules themselves are subject to full containment through the use of technology.”

    Additional industry trends impacting equipment are continuous manufacturing and digitization in an effort to optimize processes. Andreas Mattern, director of product management, Pharma, at Bosch Packaging Technology, added, “The pharmaceutical industry is changing and developing at an unprecedented pace. On the one hand, important developments in biologics, for instance for the treatment of cancer or orphan diseases, are entering the market. On the other hand, the development of continuous manufacturing equipment for oral solid dosage (OSD) is opening new potential for optimum API dosage and faster time-to-market. Moreover, digitization is also gradually entering the world of pharmaceutical production and is about to change the way we work significantly.”

    Digitization, often referred to as Industry 4.0, is a comprehensive automation, business information, and manufacturing execution strategy aimed at improving the industry via the integration of all aspects of production and commerce across a company for greater efficiency. Similarly, the internet of things, or IoT, is a system of interrelated computing devices, mechanical and digital machines, or people that are provided with unique identifiers (UIDs) and the ability to transfer data over a network without requiring human-to-human or human-to-computer interaction.

    Complex Capabilities
    Pharma and Biopharma companies increasingly look for services and capabilities that span R&D through to manufacturing, filling and packaging. Addressing the need for small to large scale manufacturing, isolator technology, integration options for multiple dosage forms, all while saving time and space, results in increasingly complex and versatile equipment.

    Matt Bundenthal, director of sales and marketing for Fette Compacting America, said, “Those exploring continuous manufacturing look for equipment that is not only applicable in terms of capacity capabilities, but also integration-friendly (notably in cases where the equipment making up the full train is sourced from different suppliers).” He added, “A more general requirement is for maximum versatility in any machine. Budgets are tighter than ever and everybody wishes to have tablet presses and encapsulators that can produce the greatest number of applicable dosage forms and sizes.”

    Optima Pharma develops and implements complex systems with technologies filling and closing, isolator technology and freeze drying, in central responsibility. According to Deininger of Optima, this includes digitized planning, integrated Factory Acceptance Test (iFAT), site management, Site Acceptance Test (SAT) and comprehensive services. “The Comprehensive Scientific Process Engineering (CSPE) method is used to ensure that as little time as possible elapses from order to start of production,” she said. “The combination of scientific methods and technological processes revolutionizes the planning and realization of pharmaceutical filling equipment.”

    Multiuse machines are most in demand as they process different primary packaging materials, such as vials, syringes, cartridges, including ready to use components, designed with a minimum space requirement. According to Deininger, “Users will also save time due to the adjustable transport system that does not require any format parts. A variety of technologies minimize product loss. Re-dosing upon request, short hose lines, 100%-In-Process-Control for vials, syringes and cartridges, weigh-dosing, re-capping upon request, and much more.”

    Pharma/Biopharma companies are thinking about manufacturing as well as packaging formats, particularly for biologics. Mattern of Bosch Packaging Technology, said, “New biologic developments call for flexible equipment that can handle ever smaller batches, while adapting to new products and packaging formats quickly.” He noted that pharmaceutical manufacturers are not simply looking for one machine, they’re looking for a partner who can accompany them throughout their projects. This can start as early as the R&D phase and go all the way to production and packaging, as well as include the underlying software requirements, qualification and validation support and service packages.

    “Consequently, the focus has shifted from merely technology-driven projects to complete solutions—including market expertise, innovative concepts and the flexibility to adapt to very specific and unique requirements. Such projects require a lot of time, experience and motivation,” Mattern said.

    Overcoming Challenges
    Equipment down-time tops the list of challenges that clients look to overcome. Leveraging digitization can help pharma/biopharma companies more accurately assess manufacturing operations, but implementation comes with its own set of challenges, particularly in an industry that faces strict regulatory requirements. 
Bundenthal of Fette Compacting America, said “Equipment down-time is a universal challenge—one that has led to the establishment of prevalent topics such as Overall Equipment Effectiveness (OEE). Capital equipment such as a tablet press or encapsulator represents a significant investment for any client, but especially for those fighting against thin budgets.

    It is therefore imperative to find new methods for maximizing the amount of ‘up time’ that any piece of equipment offers. Every moment that a high-speed machine sits idle represents lost opportunity and revenue.”

    Mattern, of Bosch Packaging Technology, said, “Digitization, Industry 4.0 or IoT—no matter what you want to call it, it’s all about using existing data to optimize processes, make them more transparent and more efficient. The pharmaceutical industry must overcome specific challenges compared to other industries because of the very strict regulations regarding safety and product quality.”

    In digitization projects, the first step is making the existing data visible in the first place. He explained how the digitization process works with two of Bosch’s products, “Our Pharma i 4.0 Starter Edition provides plant operators with essential data on their OEE, for condition monitoring of plant status or processes, and on important events like alarms or downtimes, in real time. The Pharma i 4.0 Starter Edition monitors single machines and several lines simultaneously. Once the data is available, data analyses, for instance Bosch’s Data Mining service, can help to identify new potential for higher production transparency and optimization.”

    Data mining makes it possible to assess information more effectively to identify and remedy the root causes of faults. He added, “In general, the data from two production batches is already sufficient to draw first conclusions. The more data that’s available for evaluation over a longer period, the more details will come to light.”

    Equipment Innovations
    With the growing number of biopharmaceuticals on the market, product and operator safety has become increasingly imperative. Equipment manufacturers have made great strides when it comes to the containment of high potent and cytotoxic compounds. Jones of PCI said, “Technology has advanced considerably in recent years, with manufacturers constantly evolving the solutions available. The area of contained engineering solutions whereby the molecules themselves are fully contained at every stage of the process, thereby reducing the risk of exposure to operators and the environment, is probably one of the most significant developments in recent years. This combined with geometrically similar equipment to aid scale-up and reproducibility has changed the way we are able to manage these often very potent molecules.” 

    Mattern of Bosch Packaging Technology, added, “In the production of oral solid dose forms (OSD), the need for small batch equipment with appropriate containment has also evolved in parallel with the high potency of the drugs.” Active Pharmaceutical Ingredients (APIs) can be classified into occupational exposure bands based on their potency. Categories are often referred to as OEB 1 (low hazard); OEB 2 (moderate hazard); OEB 3 (high hazard); OEB 4 (very high hazard); and OEB 5 (extremely high hazard). The new Bosch GKF 720 capsule filling machine has been developed for OEB 5 containment and is designed to ensure the highest protection for the operator, machine and product. Mattern added that the machine’s minimal water requirements, defective capsule detection and compact design can help with cost savings.

    According to Mattern, the development of continuous manufacturing equipment for OSD is opening new potential for optimum API dosage and faster time-to-market. Bosch recently introduced its new Xelum R&D to the market. The Xelum system doses mixes and granulates individual packages, so-called X-keys, which continuously run through the process chain and are removed successively from the machine into bins. Mattern said, “This way, even smallest amounts of APIs of less than 1% can be dosed precisely. It relies on the unique technology developed by Bosch’s subsidiary Hüttlin.

    Instead of the usual twin screw granulators, the Xelum platform works with well-established fluid bed processors for optimum granule quality.”

    Tremendous advances have been made in the area of capsule filling with respect to smaller footprints, increased yield and reduced costs. According to Bundenthal of Fette Compacting America, some of the most novel advances are servo-driven encapsulators. “By moving away from those that mechanically couple all of the sub-processes within the machine, one achieves a far greater degree of control over the entire process. Overall efficiencies can therefore increase dramatically. Some suppliers are even offering a double-sided encapsulator, which is entirely unprecedented. Such a machine can offer output of up to 400,000 capsules per hour—roughly twice that of the next fastest option,” Bundenthal said.

    While recent equipment innovations are dramatically improving manufacturing processes, demand for all encompassing flexibility continues. “Our customers increasingly wish for their machine solutions to cover a wide range of requirements: large and small batch sizes, ready to use syringes and bulk products, expensive and low-priced products, all possible container types such as syringes, vials, cartridges and special devices,” said Deininger of Optima. All this requires a high degree of flexibility and highly sophisticated solutions.
    Related Searches
    • packaging
    • Dosage
    • Delivery Systems
    • Regulatory
    Related Knowledge Center
    • Packaging
    • Contract Manufacturing
    • Testing
    Suggested For You
    Bone & Joint Formulas Provide Foundations for Fitness Bone & Joint Formulas Provide Foundations for Fitness
    Oral Solids Endure & Evolve Oral Solids Endure & Evolve
    GOED Releases Updated Omega-3 Ingredient Market Report GOED Releases Updated Omega-3 Ingredient Market Report
    FDA Plans to Modernize Dietary Supplement Regulations FDA Plans to Modernize Dietary Supplement Regulations
    Kerry Launches Non-GMO Yeast as Natural Solution for Acrylamide Reduction Kerry Launches Non-GMO Yeast as Natural Solution for Acrylamide Reduction
    Contract Manufacturing Survey Opportunity Contract Manufacturing Survey Opportunity
    Large Meta-Analysis Backs Benefits of Probiotic for Gut Health Large Meta-Analysis Backs Benefits of Probiotic for Gut Health
    Vitamins & Minerals: Traditions in Preventive Health Vitamins & Minerals: Traditions in Preventive Health
    GOED Updates Voluntary Monograph with Lower Lead Limit GOED Updates Voluntary Monograph with Lower Lead Limit
    Prebiotic Ingredients Market to Reach Nearly $7.7 Billion by 2025 Prebiotic Ingredients Market to Reach Nearly $7.7 Billion by 2025
    Botanical Adulterants Prevention Program Publishes Cranberry Laboratory Guidance Document Botanical Adulterants Prevention Program Publishes Cranberry Laboratory Guidance Document
    The Clean Label Tidal Wave: Dosage Delivery Forms Become Critical The Clean Label Tidal Wave: Dosage Delivery Forms Become Critical
    Lonza Consumer Health & Nutrition to Showcase Cutting-Edge Science & Innovation Lonza Consumer Health & Nutrition to Showcase Cutting-Edge Science & Innovation
    Technical Information: The Use of EMDEX® in a Lactose-free Reformulation of Cetirizine Tablets Technical Information: The Use of EMDEX® in a Lactose-free Reformulation of Cetirizine Tablets
    Is Google’s AdSense System Biased Against Dietary Supplements? Is Google’s AdSense System Biased Against Dietary Supplements?

    Related Features

    • Consumer Trends | Dietary Supplements | Healthcare Trends | Immune Function | Testing | Vitamins | Women's Health
      The Value of Vitamin D Testing

      The Value of Vitamin D Testing

      Personalized approaches to health and medicine will require nutritional status testing to more accurately recommend intake levels of many nutrients.
      By Kristina Harris Jackson, PhD, RD, Research Director, OmegaQuant, Sioux Falls, SD 01.19.21

    • Antioxidants | Contract Manufacturing | Fiber & Carbohydrates | Herbs & Botanicals | Marine Nutraceuticals | Minerals | Omega-3s | Probiotics & Prebiotics | Proteins, Peptides, Amino Acids | Vitamins
      2021 International Buyers

      2021 International Buyers' Guide

      An annual reference of companies supplying nutraceutical ingredients, products, and services around the world.
      Compiled by Nutraceuticals World Staff 12.04.20

    • Dietary Supplements | Healthcare Trends | Quality & Safety | Regulations
      State of the Industry: Positive Market Outlook Despite COVID-19 Turmoil

      State of the Industry: Positive Market Outlook Despite COVID-19 Turmoil

      Third annual survey reveals gains for businesses as consumers focus on health and wellness, but supply chain disruptions cause concern.
      By Sean Moloughney, Editor 12.04.20


    • Consumer Trends | Dietary Supplements | Healthcare Trends | Quality & Safety | Sports Nutrition
      How Sports Nutrition is Adapting to COVID-19 Upheaval

      How Sports Nutrition is Adapting to COVID-19 Upheaval

      Experts specializing in fitness, dietary supplements, and third-party testing discussed where they see the industry headed.
      By Mike Montemarano, Associate Editor 11.09.20

    • Proteins, Peptides, Amino Acids | Quality & Safety | Sports Nutrition | Testing
      Sports Nutrition in 2020: From ‘Clean’ to Compliant

      Sports Nutrition in 2020: From ‘Clean’ to Compliant

      Leaders in this marketplace offered a play-by-play on innovation, research, compliance, and more at AHPA’s Sports Nutrition Congress.
      By Mike Montemarano, Associate Editor 11.09.20

    • Herbs & Botanicals | Quality & Safety | Regulations | Testing
      Testing for Integrity: CBD & Beyond

      Testing for Integrity: CBD & Beyond

      While the regulatory landscape in the U.S. remains hazy, brands can still proactively ensure products exceed expectations for quality.
      By Sean Moloughney, Editor 11.09.20


    • Packaging | Quality & Safety
      Glass or Plastic: Understanding the Complete Costs & Sustainability Impact

      Glass or Plastic: Understanding the Complete Costs & Sustainability Impact

      Plastic packaging offers compelling advantages over glass.
      By Jeff Johnson, Director of Marketing & New Business Development, Drug Plastics & Glass Co., Inc. 11.09.20

    • Herbs & Botanicals | Quality & Safety | Regulations | Testing
      The New High Trend: Cannabis Regulation and Testing

      The New High Trend: Cannabis Regulation and Testing

      This market introduction offers insight on regulatory, testing and other considerations for cannabis-derived ingredients.
      11.02.20

    • Packaging
      Creating A Unique CBD/Cannabis ‘Global Packaging Language’

      Creating A Unique CBD/Cannabis ‘Global Packaging Language’

      How brands can differentiate themselves by communicating the effects of their products.
      By Jared Mirsky, CEO/Founder, Wick & Mortar 11.02.20


    • Herbs & Botanicals | Quality & Safety | Regulations | Testing
      A Reliable Path to Working with CBD in the U.S.

      A Reliable Path to Working with CBD in the U.S.

      The future of U.S. hemp is bright, but it will take time for the industry to mature following years of regulatory restrictions.
      By Brian Zapp, Creative Director, Applied Food Sciences 11.02.20

    • Consumer Trends | Healthcare Trends | Herbs & Botanicals | Quality & Safety | Regulations | Testing
      From Seed to Sale

      From Seed to Sale

      What formulators need to know about the hemp supply chain.
      By Nicole Foss, MBA, MSN, RN Nextraction Inc. 11.02.20

    • Consumer Trends | Packaging
      CBD Beauty: Packaging and Promises

      CBD Beauty: Packaging and Promises

      Standing out from competitors is tough. Discover how you can safely market products with packaging that makes sure your first impression is a great one.
      By Jennifer Whetzel, Founder, Ladyjane Branding 11.02.20


    • Herbs & Botanicals | Immune Function | Quality & Safety
      Preserving Quality in Immune Health Products: Weathering a Storm of Demand

      Preserving Quality in Immune Health Products: Weathering a Storm of Demand

      With unprecedented spikes and limited stocks, the most sought-after herbs are facing sustainability and quality challenges.
      By Mike Montemarano, Associate Editor 10.01.20

    • Herbs & Botanicals | Immune Function | Quality & Safety | Research
      Black Elderberry: A New Age of Science & Quality

      Black Elderberry: A New Age of Science & Quality

      With support from clinical findings and increased consumer demand, elderberry is a top ingredient in the dietary supplement and natural products industry.
      By Melanie Bush, Director of Science, Artemis International, Inc. 10.01.20

    • Cardiovascular Health | Consumer Trends | Diabetes & Blood Sugar Management | Dietary Supplements | Healthcare Trends | Herbs & Botanicals | Proteins, Peptides, Amino Acids | Quality & Safety | Weight Management/Weight Loss
      The Big Picture: Weight Wellness Trends

      The Big Picture: Weight Wellness Trends

      Consumers continue to tip the scales at a time when health hangs in the balance.
      By Sean Moloughney, Editor 09.08.20

    Trending
    • Nestlé To Sell North American Water Brands
    • House Resolution Calls For CDC And FDA To Back Vitamin D For COVID-19
    • Innova: Top Trends In Dairy Focus On Holistic Benefits
    • Carlson Launches New Grade Of Astaxanthin Gummies With Astaferm
    • Curcuminoid Complex Study Evidences Benefits To Gut Health And Mood
    Breaking News
    • Martin Bauer Group Acquires Majority Stake in Beverage Company Power Brands
    • Gencor Announces Positive Results in VeriSperse Bioavailability Study
    • PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC
    • Nutrition21 Launches Cosmeceutical Ingredient Lustriva
    • Indena Becomes First Company in Italy Authorized to Produce CBD
    View Breaking News >
    CURRENT ISSUE

    Jan/Feb 2021

    • Modern Snacking: Where Health & Indulgence Converge
    • More Than Just A Trend: Supplements Embedded in Consumer Health Regimens
    • A Growing Need for Mineral Supplementation
    • The Value of Vitamin D Testing
    • A Glance At The Eye Health Market
    • Citrus Support for the Blood Glucose-Immune System Connection
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Martin Bauer Group Acquires Majority Stake in Beverage Company Power Brands
    Gencor Announces Positive Results in VeriSperse Bioavailability Study
    PanTheryx Inc. Acquires TruBiotics Brand from Bayer HealthCare LLC
    Coatings World

    Latest Breaking News From Coatings World

    Mule-Hide Products Co. Promotes Steven Litaker to Territory Manager
    Terra Firma, Wanhua Announce New Distribution Partnership
    Gelest CEO Elected to National Academy of Engineering
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    Axonics Buys Contura to Expand to Stress Urinary Incontinence
    Nurx Appoints Chief Medical Officer
    Median Technologies, UC San Diego to Partner on AI-Based Medical Imaging Technology
    Contract Pharma

    Latest Breaking News From Contract Pharma

    J&J’s Single-Dose COVID-19 Vax Issued EUA
    Icon to Acquire PRA Health Sciences
    Phlow Corp. and USP Form Alliance
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    Universal Engraving Announces New President
    Raw Sugar Living Expands to Target with New Collection
    Supporting Female Beauty Brand Founders on International Women's Day
    Happi

    Latest Breaking News From Happi

    ACI and CBC Launch Webpage About ‘Quats’
    L’Occitane Launches Hand Cream Inspired by Women
    Kiehl’s Partners with Gyrl Wonder
    Ink World

    Latest Breaking News From Ink World

    Access Direct Mail Doubles Revenue with SCREEN's Truepress Jet520HD
    Etiflex Enters New Markets with Nilpeter FA-22 Installation
    Hydrocarbon Solvents Market to Surpass $8.1 Billion by 2030
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    TLMI analyzes pandemic's effect on label industry in new report
    UEI names Ross Hutchison president
    Schreiner MediPharm and AARDEX partner for clinical trials
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    U.S. Nonwovens Rebrands as Radienz Living
    What You’re Reading on Nonwovens-Industry.com
    Texas Medical Technology Partners with My Protect Kit
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    Pandemic Pain: NuVasive's 2020 Sales Fall 10 Percent
    Fusion Robotics Receives FDA Clearance for Spinal Navigation and Robotics System
    Kaia Health Unveils Next-Gen Complete MSK Care Solutions
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Comercial Kywi Improves Customer Service, Front-Store Operations with Zebra Mobile Solution
    Global Printed Circuit Board Market Projected to Reach $69.32 Billion by 2027
    Global Smart Glass Market to Register 6.8% CAGR Between 2021-28: Grand View Research

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login